How we manage prostate biopsy and prostate cancer therapy in men with haemophilia

9Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A 56-year-old African American male with severe haemophilia A [baseline factor VIII (FVIII) activity <1%] and chronic hepatitis C virus infection started annual serial monitoring of prostate-specific antigen (PSA) at age 40 because of a family history of prostate cancer (his father died from the disease at age 63). His most recent PSA level was 4.4ngL -1 ; previous values were <3ngL -1. Digital rectal examination was unrevealing. © 2012 Blackwell Publishing Ltd.

Cite

CITATION STYLE

APA

Fogarty, P. F., & Kouides, P. (2012, May). How we manage prostate biopsy and prostate cancer therapy in men with haemophilia. Haemophilia. https://doi.org/10.1111/j.1365-2516.2012.02787.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free